
X
Sosei Heptares bags another big partnership, this time with Takeda
https://pharmaphorum.com/news/sosei-heptares-bags-another-big-partnership-this-time-with-takeda/
Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.
Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.
Phase 1 study of immuno-oncology drug candidate begins.